TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103. A total of 52 filers reported holding TARSUS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $38,038,213 | +18.3% | 2,140,586 | +20.3% | 5.37% | +13.4% |
Q2 2023 | $32,149,385 | +25.7% | 1,779,158 | -12.5% | 4.73% | +24.2% |
Q1 2023 | $25,569,366 | -12.9% | 2,034,158 | +1.6% | 3.81% | -10.6% |
Q4 2022 | $29,343,236 | -18.0% | 2,001,585 | -4.2% | 4.26% | -2.8% |
Q3 2022 | $35,778,000 | +17.6% | 2,089,856 | +0.3% | 4.39% | -5.0% |
Q2 2022 | $30,432,000 | +503.1% | 2,084,370 | +594.8% | 4.62% | +357.7% |
Q1 2022 | $5,046,000 | – | 300,000 | – | 1.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 1,417,157 | $41,069,000 | 3.79% |
Vivo Capital, LLC | 2,987,331 | $86,573,000 | 3.75% |
Cormorant Asset Management, LP | 1,514,269 | $43,884,000 | 1.49% |
Ghost Tree Capital, LLC | 170,000 | $4,927,000 | 1.35% |
RTW INVESTMENTS, LP | 2,013,601 | $58,354,000 | 0.88% |
COWEN AND COMPANY, LLC | 514,289 | $14,904,000 | 0.78% |
Perceptive Advisors | 2,592,832 | $75,140,000 | 0.49% |
Altium Capital Management LP | 70,573 | $2,045,000 | 0.47% |
TimesSquare Capital Management, LLC | 686,705 | $19,901,000 | 0.16% |
Jefferies Group LLC | 442,993 | $12,837,937 | 0.08% |